Active, Not Recruiting
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
NCT03628209
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +6 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Children's Hospital of Los Angeles, USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Children's Hospital of Colorado Aurora, Colorado, United States
- Connecticut Children's Medical Center Hartford, Connecticut, United States